L
Laurence Jesel
Researcher at University of Strasbourg
Publications - 155
Citations - 6552
Laurence Jesel is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Acute coronary syndrome & Medicine. The author has an hindex of 34, co-authored 139 publications receiving 5592 citations. Previous affiliations of Laurence Jesel include French Institute of Health and Medical Research & Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Sudden Cardiac Arrest Associated with Early Repolarization
Michel Haïssaguerre,Nicolas Derval,Frederic Sacher,Laurence Jesel,Isabel Deisenhofer,Luc De Roy,Jean-Luc Pasquié,Akihiko Nogami,Dominique Babuty,Sinikka Yli-Mäyry,Christian de Chillou,Patrice Scanu,Philippe Mabo,Seiichiro Matsuo,Vincent Probst,Solena Le Scouarnec,Pascal Defaye,Juerg Schlaepfer,Thomas Rostock,Dominique Lacroix,Dominique Lamaison,Thomas Lavergne,Yoshifusa Aizawa,Anders Englund,Frédéric Anselme,Mark D O'Neill,Mélèze Hocini,Kang-Teng Lim,Sébastien Knecht,George D. Veenhuyzen,Pierre Bordachar,Michel Chauvin,Pierre Jaïs,Gaelle Coureau,Geneviève Chêne,George Klein,Jacques Clémenty +36 more
TL;DR: Among patients with a history of idiopathic ventricular fibrillation, there is an increased prevalence of early repolarization and during a mean (+/-SD) follow-up of 61+/-50 months, defibrillator monitoring showed a higher incidence of recurrent ventricularfibrillation in case subjects with a repolarized abnormality than in those without such an abnormality.
Journal ArticleDOI
Driver Domains in Persistent Atrial Fibrillation
Michel Haïssaguerre,Mélèze Hocini,Arnaud Denis,Ashok J. Shah,Yuki Komatsu,Seigo Yamashita,Matthew Daly,Sana Amraoui,Stephan Zellerhoff,Marie-Quitterie Picat,Adam Quotb,Laurence Jesel,Han S. Lim,Sylvain Ploux,Pierre Bordachar,Guillaume Attuel,Valentin Meillet,Philippe Ritter,Nicolas Derval,Frederic Sacher,Olivier Bernus,Hubert Cochet,Pierre Jaïs,Rémi Dubois +23 more
TL;DR: Persistent AF in early months is maintained predominantly by drivers clustered in a few regions, most of them being unstable reentries.
Journal ArticleDOI
Cellular Mechanisms Underlying the Formation of Circulating Microparticles
TL;DR: Because PS exposure is a key feature in pathological processes different from hemostasis and thrombosis, the most important obstacle in the field of MP-modulating drugs seems to be carefully targeting MP release to relevant cell types at an optimal level, so as to achieve a beneficial action and limit possible adverse effects.
Journal ArticleDOI
Clinical Aspects and Prognosis of Brugada Syndrome in Children
Vincent Probst,Isabelle Denjoy,Paola G. Meregalli,Jean Christophe Amirault,Frederic Sacher,Jacques Mansourati,Dominique Babuty,Elisabeth Villain,Jacques Victor,Jean-Jacques Schott,Jean Marc Lupoglazoff,Philippe Mabo,Christian Veltmann,Laurence Jesel,Philippe Chevalier,S. A. Clur,Michel Haïssaguerre,Christian Wolpert,Hervé Le Marec,Arthur A.M. Wilde +19 more
TL;DR: In the largest population of children affected by Brugada syndrome described to date, fever represented the most important precipitating factor for arrhythmic events, and as in the adult population, the risk of arrhythmmic events was higher in previously symptomatic patients and in those displaying a spontaneous type I ECG.
Journal ArticleDOI
Procoagulant Membrane Microparticles Correlate with the Severity of Pulmonary Arterial Hypertension
Babe Bakouboula,Olivier Morel,Antoine Faure,Fatiha Zobairi,Laurence Jesel,Annie Trinh,Michel Zupan,Matthieu Canuet,Lelia Grunebaum,Agnès Brunette,Dominique Desprez,François Chabot,Emmanuel Weitzenblum,Jean-Marie Freyssinet,Ari Chaouat,Florence Toti +15 more
TL;DR: Circulating markers of endothelium damage, proinflammatory markers, and cell stimulation estimated with circulating microparticles appear to be valuable tools in determining the severity of PAH.